Question 1: Name of Product: (for most recent cell therapy infusion)

The name of the product reported will be auto populated with the value reported on the Pre-Cellular Therapy Essential Data (4000) form. If the cellular therapy product infused is a commercially available or pre-commercial product, this question is used to enable questions related to toxicities and disable questions that do not apply.

Combined follow up
In scenarios where both HCT and cellular therapy forms are being completed, and the recipient has received the HCT after the cellular therapy, the product name should be for the prior cellular therapy product.

Section Updates:

Question Number Date of Change Add/Remove/Modify Description Reasoning (If applicable)
1 7/29/2021 Remove Removed blue note box below question 1: If your center considers this to be a Donor Lymphocyte Infusions (DLI), as reported on the Pre-CTED (4000) form, product name will not be auto-populated. Select Other product for the product name. DLIs are no longer reported on the F4100.
Last modified: Sep 23, 2022

Need more help with this?
Don’t hesitate to contact us here.

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.